Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 CNS 1

Conditions

Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Pancreatic Neoplasms 1 Melanoma 1 Low-grade Glioma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Craniopharyngioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

tovorafenib 1 Psychotherapy, Multiple 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Low-grade Glioma × tovorafenib × Clear all

NCT04775485 2025-04-10

FIREFLY-1

Day One Biopharmaceuticals, Inc.

Phase 2 Recruiting

141 enrolled 1 FDA

CNSOther solid neoplasm

Low-grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡